Featured Research

from universities, journals, and other organizations

Stem Cells Grown In Lab Mirror Normal Developmental Steps

Date:
June 22, 2005
Source:
Johns Hopkins Medical Institutions
Summary:
Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.

Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.

The process avoids some of the ethical and technical obstacles involved in such research, according to the Johns Hopkins investigators.

The Johns Hopkins researchers' system involves the study of existing embryonic stem cell lines derived from in vitro fertilization methods, and so doesn't require generation of embryos through cloning, a technique recently reported by South Korean scientists.

In their report on the work in the June issue of the journal Blood, the Johns Hopkins team demonstrated a clear similarity between how human embryonic stem cells specialize into blood cells and how blood cells develop in human embryos.

"Our findings provide an unparalleled opportunity to study the basic questions of human development, like 'Where does blood come from?'" says Elias Zambidis, M.D., Ph.D., first author on the paper and an assistant professor of pediatrics and oncology in the Johns Hopkins School of Medicine.

Knowing the steps by which stem cells develop into blood cells are likely to help medical researchers figure out how to treat cancers of the blood, such as leukemia and lymphoma, Zambidis notes.

"More and more we're learning that the genes that turn on in the embryo to make blood stem cells are the same genes that go wrong in cancer," he says. "So if we understand what the important genes are and how they work, we might be able to develop and to target new cancer therapies more effectively."

Historically, scientists have worked on mouse and zebrafish models of embryological blood cell development, but ethical and technical barriers have stood in the way of an in-depth study of blood formation in human embryos. In the new work, Hopkins scientists and colleagues from the University of Pittsburgh School of Medicine used laboratory-grown dishes of human stem cells, in clumps called human embryoid bodies, and observed three distinct steps taken by stem cells on their way to becoming blood cells.

Without any chemical manipulation or stimulation, the clusters of human stem cells first became colonies of cells that can produce endothelium, or the tissue that makes up the circulatory system. These colonies can then also form the precursors of blood cells, in a structure similar to the yolk sac of human embryos. Finally, some of the cells in the colonies form blood cells similar to those found in the liver and bone marrow of a developing fetus, making it simple for the researchers to pick out the blood cells for further investigation. "We were quite surprised to find that these steps proceeded spontaneously, without the need for stimulation by growth factors or other chemicals," says Zambidis. "It's likely that the same method of picking out certain kinds of cells could be used to study processes other than blood cell development."

Most importantly, Zambidis says, the stages of blood cell development he and his team found in the stem cell lines correlate with what is already known about early stages of human blood cell development in embryos in the womb. "We've captured these phases of stem cell specialization, or differentiation, in a dish," says Zambidis. "Now we can study these phases and hopefully help solve the Rubik's Cube of how human development works."

Because embryonic stem cells are capable of becoming virtually every type of cell in the human body, understanding how they do so might provide the chance to harness that process to make a limitless supply of specific cells for therapeutic purposes. For instance, stem cells directed down the path of blood cell development might be useful to help treat leukemias or other blood disorders.

Zambidis and colleagues are currently using their model to study the next stage in blood cell development, which in a growing embryo involves blood cell precursors moving from the yolk sac into the liver, bone marrow and thymus. Zambidis says that if blood stem cells are to be used for therapeutic purposes, they would likely come from this next stage of development.

###

The research was funded by grants from the National Institutes of Health and from the American Society of Clinical Oncology. Authors on the paper are Zambidis, Fred Bunz and Curt Civin of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; and Bruno Peault and Tea Soon Park of the Department of Pediatrics at the University of Pittsburgh School of Medicine.

On the Web:
http://www.bloodjournal.org


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Stem Cells Grown In Lab Mirror Normal Developmental Steps." ScienceDaily. ScienceDaily, 22 June 2005. <www.sciencedaily.com/releases/2005/06/050621094447.htm>.
Johns Hopkins Medical Institutions. (2005, June 22). Stem Cells Grown In Lab Mirror Normal Developmental Steps. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2005/06/050621094447.htm
Johns Hopkins Medical Institutions. "Stem Cells Grown In Lab Mirror Normal Developmental Steps." ScienceDaily. www.sciencedaily.com/releases/2005/06/050621094447.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins